Advertisement

Topics

Ra Pharmaceuticals to Host Conference Call on Initial Phase 2 Data for RA101495 in PNH

16:30 EDT 21 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Ra Pharmaceuticals, Inc. (NASDAQ:RARX) today announced that it will host a conference call and webcast on Tuesday, June 27, 2017 to discuss initial data from the Company’s global Phase 2 clinical program evaluating RA10...

Other Sources for this Article

Investors:
Ra Pharmaceuticals, Inc.
Jennifer Robinson, 617-674-9873
jrobinson@rapharma.com
or
Media:
Argot Partners
Eliza Schleifstein, 917-763-8106
eliza@argotpartners.com

NEXT ARTICLE

More From BioPortfolio on "Ra Pharmaceuticals to Host Conference Call on Initial Phase 2 Data for RA101495 in PNH"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...